Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violaine K Harris

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Diagnosis & Therapy|August 29, 2014
Biomarkers of therapeutic response in multiple sclerosis: current statusViolaine K Harris, Saud A Sadiq
Neurodegenerative Disease Management|June 25, 2015
Stem cell therapy in multiple sclerosis: a future perspectiveViolaine K Harris, Saud A Sadiq
Molecular Diagnosis & Therapy|August 29, 2009
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision makingViolaine K Harris, Saud A Sadiq
Cytotherapy|October 12, 2016
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosisViolaine K Harris, Tamara Vyshkina, Saud A Sadiq
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Biomarkers of multiple sclerosis: current findingsViolaine K Harris, John F Tuddenham, Saud A Sadiq
Molecular and Cellular Biology|August 5, 2003
A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptorGuizhong Liu, Anna Bafico, Violaine K Harris, et al.
Stem Cells Translational Medicine|December 1, 2012
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosisViolaine K Harris, Raihan Faroqui, Tamara Vyshkina, et al.
Plos One|August 11, 2023
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosisViolaine K Harris, Jaina Wollowitz, Jacelyn Greenwald, et al.
Neurobiology of Disease|July 6, 2010
Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosisViolaine K Harris, Andrew Diamanduros, Pamela Good, et al.
Plos One|April 8, 2017
Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune responseViolaine K Harris, Lena Bell, Ruth-Anne Langan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Diagnosis & Therapy|August 29, 2014
Biomarkers of therapeutic response in multiple sclerosis: current statusViolaine K Harris, Saud A Sadiq
Neurodegenerative Disease Management|June 25, 2015
Stem cell therapy in multiple sclerosis: a future perspectiveViolaine K Harris, Saud A Sadiq
Molecular Diagnosis & Therapy|August 29, 2009
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision makingViolaine K Harris, Saud A Sadiq
Cytotherapy|October 12, 2016
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosisViolaine K Harris, Tamara Vyshkina, Saud A Sadiq
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Biomarkers of multiple sclerosis: current findingsViolaine K Harris, John F Tuddenham, Saud A Sadiq
Molecular and Cellular Biology|August 5, 2003
A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptorGuizhong Liu, Anna Bafico, Violaine K Harris, et al.
Stem Cells Translational Medicine|December 1, 2012
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosisViolaine K Harris, Raihan Faroqui, Tamara Vyshkina, et al.
Plos One|August 11, 2023
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosisViolaine K Harris, Jaina Wollowitz, Jacelyn Greenwald, et al.
Neurobiology of Disease|July 6, 2010
Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosisViolaine K Harris, Andrew Diamanduros, Pamela Good, et al.
Plos One|April 8, 2017
Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune responseViolaine K Harris, Lena Bell, Ruth-Anne Langan, et al.
Pageof 2